Literature DB >> 11963773

[Familial prostate carcinoma in Germany].

T Paiss1, K Herkommer, A Chab, J Häussler, W Vogel, J E Gschwend, R E Hautmann.   

Abstract

Epidemiologic studies have shown that hereditary forms account for approximately 10% of all prostate cancers. The identification of several susceptibility loci harboring predisposing genes indicates the genetic heterogeneity of prostate cancer. The conflicting results of different linkage analyses may be explained by a varying contribution of each locus within different family collections and reflect differences of allele frequencies across different populations. In the present study we recorded the incidence of familial prostate cancer in Germany and performed descriptive analysis of the epidemiological data. In spite of a significant ascertainment bias, only 19% of all prostate cancers were familial. In 94% of families there were three affected relatives at most. Large prostate cancer families with at least five affected persons were rare (2%). Descriptive analysis revealed that only 42% of all pedigrees followed an autosomal-dominant pattern of transmission; the other pedigrees showed an X-chromosomal or recessive mode of inheritance. These data confirm the genetic heterogeneity of hereditary prostate cancer and imply that previously published epidemiological data cannot be transferred to the German population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11963773     DOI: 10.1007/s120-002-8229-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  7 in total

1.  [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].

Authors:  T Paiss; D Kahn; R Küfer; C Maier; W Vogel; J E Gschwend; R E Hautmann; K Herkommer
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

2.  [Internet use after prostate cancer : Search for information and trust in disease-related information in long-term survivors].

Authors:  A J Linden; A Dinkel; S Schiele; V H Meissner; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2019-09       Impact factor: 0.639

Review 3.  [Prostate and breast cancer: similarities and differences].

Authors:  Jennifer Kranz; Marco Hoffmann; Katja Krauß; Elmar Stickeler; Matthias Saar
Journal:  Urologie       Date:  2022-08-29

4.  [Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy].

Authors:  T Paiss; B Bock; J E Gschwend; H Heinz; W Vogel; M Kron; R E Hautmann; K Herkommer
Journal:  Urologe A       Date:  2003-03-14       Impact factor: 0.639

Review 5.  [Molecular diagnostics of prostate cancer].

Authors:  J Kamradt; M Stöckle; B Wullich
Journal:  Urologe A       Date:  2003-04-03       Impact factor: 0.639

6.  No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance.

Authors:  Kathleen Herkommer; Nikola Maier; Donna P Ankerst; Stefan Schiele; Jürgen E Gschwend; Valentin H Meissner
Journal:  World J Urol       Date:  2020-10-13       Impact factor: 4.226

7.  Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance.

Authors:  Valentin H Meissner; Mira Woll; Donna P Ankerst; Stefan Schiele; Jürgen E Gschwend; Kathleen Herkommer
Journal:  World J Urol       Date:  2021-05-10       Impact factor: 4.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.